The ESC 2021 and 2022 ACC/AHA guidelines highlight the importance of BNP/NT-proBNP testing in ruling out HF in the emergency setting, as well as recommend its measurement for risk stratification and the establishment of a prognosis [31]. This evidence concerns the gene NPPB and hydrops fetalis.